publication date: Jan. 20, 2017

Funding Opportunities

LUNGevity issues RFA for career development award

LUNGevity announced a request for applications for translational research for career development awards that will be granted in 2017.

The RFA is available on the LUNGevity website at
and is also posted on the proposalCENTRAL website at

LUNGevity’s career development awards for translational research program was created to support future research leaders who will keep the field of lung cancer research vibrant with new ideas.

Successful applicants may receive $100,000 per year for a possible period of three years and will participate as non-voting members of LUNGevity’s scientific advisory board for the duration of the award. Applicants must be within the first five years of their
faculty appointment.

The career development awards are mentored awards, and a mentoring plan is part of the required submission. Projects that will be funded in 2017 are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment, including through targeted therapy
and immunotherapy.

Letters of intent must be submitted by Feb. 20. LUNGevity supports the largest research awards program of any lung cancer-focused organization in the United States. Since 2002, LUNGevity has funded 118 projects at 58 institutions in 23 states.

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.